Drug intelligence / Profile preview

estradiol valerate + norgestrel

Development stage
Phase 3
Lead developer
Bayer
Modality
Small Molecules
Administration
Oral
01

Overview

Estradiol valerate + norgestrel is a combination hormone replacement therapy (HRT) medication containing two female sex hormones: estradiol valerate (an estrogen) and norgestrel (a progestogen). The estradiol component is equivalent to the natural hormone and possesses the same properties, while norgestrel has an effect similar to the natural corpus luteum hormone progesterone. This combination is primarily used for hormone replacement therapy in menopausal women to help restore hormonal balance after the ovaries cease producing these hormones naturally. The medication is typically supplied as a sequential regimen with white tablets containing only estradiol valerate (2 mg) followed by light brown tablets containing both estradiol valerate (2 mg) and norgestrel (0.5 mg).

Brand names
ProgylutonCyclo-Progynova
02

Targets

ESR1 (ERα)SHBG (Sex hormone-binding globulin)ESR2 (ERβ)GPER1 (G protein-coupled estrogen receptor 1)PR (Progesterone receptor)

Beyond the preview

Go deeper on estradiol valerate + norgestrel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on estradiol valerate + norgestrel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call